The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 14, 2018
Filed:
May. 26, 2016
Applicant:
Novartis Ag, Basel, CH;
Inventors:
Zijun Chen, Shanghai, CN;
Sujun Deng, Shanghai, CN;
Yun He, Shanghai, CN;
Dagang Huang, Shanghai, CN;
Markus Kugler, Planegg, DE;
Qian Li, Shanghai, CN;
Chris Xiangyang Lu, Shanghai, CN;
Xiao Luo, Shanghai, CN;
Yongqiang Shan, Shanghai, CN;
Kathrin Ulrike Tissot-Daguette, Planegg, DE;
Jing Wu, Shanghai, CN;
Assignee:
NOVARTIS AG, Basel, CH;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/22 (2006.01); A61K 39/395 (2006.01); A61K 38/18 (2006.01); C12N 15/13 (2006.01); C12N 15/63 (2006.01); C12N 15/09 (2006.01); A61K 45/06 (2006.01); A61K 31/155 (2006.01); A61K 31/355 (2006.01); A61K 31/4439 (2006.01); A61K 31/4725 (2006.01); A61K 31/497 (2006.01); A61K 31/513 (2006.01); A61K 31/522 (2006.01); A61K 31/575 (2006.01); A61K 31/675 (2006.01); A61K 31/7072 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/22 (2013.01); A61K 31/155 (2013.01); A61K 31/355 (2013.01); A61K 31/4439 (2013.01); A61K 31/4725 (2013.01); A61K 31/497 (2013.01); A61K 31/513 (2013.01); A61K 31/522 (2013.01); A61K 31/575 (2013.01); A61K 31/675 (2013.01); A61K 31/7072 (2013.01); A61K 38/1875 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); C12N 15/09 (2013.01); C12N 15/63 (2013.01); A61K 2039/505 (2013.01); C07K 2317/21 (2013.01); C07K 2317/24 (2013.01); C07K 2317/33 (2013.01); C07K 2317/34 (2013.01); C07K 2317/51 (2013.01); C07K 2317/515 (2013.01); C07K 2317/55 (2013.01); C07K 2317/73 (2013.01); C07K 2317/76 (2013.01); C07K 2317/90 (2013.01); C07K 2317/92 (2013.01); C07K 2317/94 (2013.01);
Abstract
The present invention relates to isolated antibodies and antigen-binding fragments thereof which bind human BMP9 and compositions and methods of use thereof.